#news #biotech Metabotropic glutamate receptor structures reveal potential drug target for neurological diseases

Biotechnology, Pharma and Biopharma News – Research – Science – Lifescience ://Biotech-Biopharma-Pharma: Metabotropic glutamate receptor structures reveal potential drug target for neurological diseases .Metabotropic glutamate receptors (mGlus), which belong to class C G-protein-coupled receptor (GPCR) family, play key roles in modulating neuronal excitability and synaptic transmission in the central nervous system. The mGlus (mGlu1-8) identified in humans serve as therapeutic targets for a variety of neurological and psychiatric disorders such as Parkinson’s disease, Alzheimer’s disease and schizophrenia, but drugs targeting the mGlus are not currently available.

from Biotechnology News – Biology News https://ift.tt/3q3zyXM